Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality
Authors
Keywords
-
Journal
COPD-Journal of Chronic Obstructive Pulmonary Disease
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2021-09-21
DOI
10.1080/15412555.2021.1977789
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Perplexing mortality data from triple therapy trials in COPD
- (2021) Samy Suissa Lancet Respiratory Medicine
- Fixed Triple Therapy in COPD and Survival: Living Better, Longer, or Both?
- (2020) Jørgen Vestbo AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients
- (2020) David A. Lipson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Re-Igniting the TORCH: COPD Mortality and Inhaled Corticosteroids Re-Visited
- (2020) Peter Calverley AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for COPD: A Randomized, Double-Blind, Multi-Center Parallel-Group Study
- (2020) Fernando J. Martinez et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum
- (2019) Achim Wolf et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice
- (2019) Samy Suissa et al. CHEST
- Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD
- (2019) Samy Suissa et al. CHEST
- Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
- (2019) Rishi J Desai et al. BMJ-British Medical Journal
- Making Sense of Triple Inhaled Therapy for COPD
- (2018) Samy Suissa et al. NEW ENGLAND JOURNAL OF MEDICINE
- GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)
- (2018) Cristina Rebordosa et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Single-Inhaler Triple versus Dual Therapy in Patients with COPD
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Triple therapy trials in COPD: a precision medicine opportunity
- (2018) Samy Suissa et al. EUROPEAN RESPIRATORY JOURNAL
- Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study
- (2018) Samy Suissa et al. Lancet Respiratory Medicine
- Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20th Anniversary: a brief history of time
- (2017) Roberto Rodriguez-Roisin et al. EUROPEAN RESPIRATORY JOURNAL
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
- (2017) Claus F. Vogelmeier et al. EUROPEAN RESPIRATORY JOURNAL
- Run-in bias in randomised trials: the case of COPD medications
- (2017) Samy Suissa EUROPEAN RESPIRATORY JOURNAL
- Evidence for Health Decision Making — Beyond Randomized, Controlled Trials
- (2017) Thomas R. Frieden NEW ENGLAND JOURNAL OF MEDICINE
- Eosinophils in COPD: just another biomarker?
- (2017) Mona Bafadhel et al. Lancet Respiratory Medicine
- Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
- (2016) Jørgen Vestbo et al. LANCET
- Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice
- (2016) Jørgen Vestbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-World Evidence — What Is It and What Can It Tell Us?
- (2016) Rachel E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores
- (2016) Samy Suissa et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records
- (2016) Kieran J Rothnie et al. Clinical Epidemiology
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)
- (2015) Emily Herrett et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)
- (2014) J. K. Quint et al. BMJ Open
- Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
- (2012) Philip H. Quanjer et al. EUROPEAN RESPIRATORY JOURNAL
- Accuracy of pneumonia hospital admissions in a primary care electronic medical record database
- (2012) Sharon B. Meropol et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The incident user design in comparative effectiveness research
- (2012) Eric S. Johnson et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Effects of Adjusting for Instrumental Variables on Bias and Precision of Effect Estimates
- (2011) Jessica A. Myers et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Validation and validity of diagnoses in the General Practice Research Database: a systematic review
- (2009) Emily Herrett et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now